SCHEMBL4281322

SCHEMBL4281322

COC(=O)Cc1cc(C(=O)O)ccc1OCC(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
HIF1A Q16665 1/20 0.51
FOS P01100 2/20 0.50
JUN P05412 2/20 0.50
TSHR P16473 2/20 0.46
HTT P42858 2/20 0.46
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.46
XDH P47989 1/20 0.46
MYC P01106 2/20 0.46
MAX P61244 2/20 0.46
EP300 Q09472 2/20 0.46
NR1H4 Q96RI1 2/20 0.45
PLA2G2D Q9UNK4 1/20 0.45
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2964502 0.87 FOS (0.60) ALDH1A1HIF1AFOSJUNTSHR
SCHEMBL4289001 0.83 MYC (0.47) ALDH1A1HIF1AFOSJUNTSHR
SCHEMBL4291381 0.82 FOS (0.55) ALDH1A1HIF1AFOSJUNTSHR
SCHEMBL4276973 0.80 ALDH1A1 (0.44) ALDH1A1HIF1AFOSJUNTSHR
SCHEMBL4279253 0.79 FOS (0.52) ALDH1A1HIF1AFOSJUNTSHR
SCHEMBL4280457 0.79 FOS (0.60) ALDH1A1HIF1AFOSJUNTSHR
SCHEMBL4275354 0.79 CA12 (0.67) TSHRHTTMYCMAXLMNA
SCHEMBL17908022 0.79 TSHR (0.69) TSHRHTTLMNAMAPK1RAB9A
SCHEMBL4280428 0.79 ADRB2 (0.49) HTTLMNA
SCHEMBL27594611 0.78 FOS (0.59) ALDH1A1HIF1AFOSJUNTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-05-07 US disclosed
US-7314888-B1 Compounds and medicinal use thereof TOYAMA CHEMICAL CO., LTD. (JP) 2008-01-01 US disclosed
CN-1325376-A Novel compound and medical use thereof TOYAMA CHEMICAL CO LTD (JP) 2001-12-05 CN disclosed
EP-1127869-A1 NOVEL COMPOUNDS AND MEDICINAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2001-08-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF SP1, AP1G1, AP1M1 ALDH1A1 2031/4885HIF1A 471/4885FOS 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.